Initial experience of preoperative gemcitabine and cisplatin plus durvalumab followed by resection for high-risk biliary tract cancer.
Matthew H. G. Katz, Yun Shin Chun, Hop S. Tran Cao, Milind M. Javle et al.
Citations
1 citations
Journal
Journal of Clinical Oncology
Topics
Cholangiocarcinoma and Gallbladder Cancer Studies
Field-Weighted Citation Impact (FWCI)
2.01
article
Initial experience of preoperative gemcitabine and cisplatin plus durvalumab followed by resection for high-risk biliary tract cancer.
Matthew H. G. Katz, Yun Shin Chun, Hop S. Tran Cao, Milind M. Javle, Timothy Eric Newhook, Ching‐Wei D. Tzeng, Shubham Pant, Jean‐Nicolas Vauthey, Elena Panettieri, Antony Haddad, Madhulika Eluri, Zishuo Ian Hu
article en
1 citations
Abstract
No abstract available for this paper.
Publication Tag
Journal of Clinical OncologyVol. 43(16_suppl)
Institutions
The University of Texas MD Anderson Cancer Center (US)